Ken Trbovich

Stock Analyst

(n/a)

# 4,425

Out of 4,433 analysts

6

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic Biotechnology

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CARA Cara Therapeutics	Upgrades: Buy	n/a	$0.75	-	2	Feb 12, 2018
	SUPN Supernus Pharmaceuticals	Upgrades: Buy	n/a	$29.10	-	1	Dec 4, 2017
	PCRX Pacira BioSciences	Downgrades: Sell	n/a	$30.82	-	3	Oct 26, 2017

Cara Therapeutics

Feb 12, 2018

Upgrades: Buy

Price Target: n/a

Current: $0.75

Upside: -

Supernus Pharmaceuticals

Dec 4, 2017

Upgrades: Buy

Price Target: n/a

Current: $29.10

Upside: -

Pacira BioSciences

Oct 26, 2017

Downgrades: Sell

Price Target: n/a

Current: $30.82

Upside: -